Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (RC2 Clinical Trials Optional)
Last verified by NonDilute: 2026-06-08. Official notice and agency instructions control.
If your CTSA Hub has a critical unmet need in clinical research infrastructure or capabilities, this funds you to build and demonstrate a solution for network-wide adoption.
Report stale or inaccurate summary
What this is
This is a limited-competition program designed exclusively for institutions already operating as UM1 CTSA Program Hubs. It funds development of innovative hub capabilities, research platforms, and shared resources that address roadblocks in clinical and translational science. Successful projects should create foundations for adoption and dissemination across the broader CTSA network. This is infrastructure and platform funding, not investigator-initiated research.
Who can apply
Eligibility is strictly limited to public and state-controlled institutions of higher education that are already awarded UM1 Clinical and Translational Science Award (CTSA) Program Hub status. Solo founders, startups, and non-hub institutions are ineligible.
Eligible applicant types
- Public and State controlled institutions of higher education
Full description — from the agency
The purpose of the High Impact Specialized Innovation Programs (SIPs) is to support the development and demonstration of unique hub capabilities, research platforms and/or resources to address in a timely manner critical gap areas and/or roadblocks in clinical and translational science at awarded UM1 Clinical and Translational Science Awards (CTSA) Program Hubs (PAR-24-272). Successful programs supported through this funding opportunity are expected to lay a strong foundation for future adoption and/or dissemination of capabilities to additional CTSA Program Hubs.
Topics: clinical and translational science · CTSA hub innovation · research infrastructure · clinical trial platforms · biomedical research resources
Public-source funding discovery only. This summary is generated from public agency data and may be incomplete or stale. NonDilute is not affiliated with, endorsed by, or acting on behalf of any government agency. Official notices and agency instructions control. NonDilute does not determine eligibility, provide grant-writing advice, or guarantee funding.